000 -LEADER |
fixed length control field |
04341nam a22004455i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20140310150653.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
100803s2010 gw | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783540705796 |
|
978-3-540-70579-6 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC254-282 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.994 |
Edition number |
23 |
264 #1 - |
-- |
Berlin, Heidelberg : |
-- |
Springer Berlin Heidelberg : |
-- |
Imprint: Springer, |
-- |
2010. |
912 ## - |
-- |
ZDB-2-SME |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Schneider, Paul M. |
Relator term |
editor. |
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
Title |
Adenocarcinoma of the Esophagogastric Junction |
Medium |
[electronic resource] / |
Statement of responsibility, etc |
edited by Paul M. Schneider. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
XIV, 194 p. |
Other physical details |
online resource. |
440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
Recent Results in Cancer Research, |
International Standard Serial Number |
0080-0015 ; |
Volume number/sequential designation |
182 |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Epidemiology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third -- Clinical Classification Systems of Adenocarcinoma of the Esophagogastric Junction -- Histopathologic Classification of Adenocarcinoma of the Esophagogastric Junction -- The Pathogenesis of Barrett’s Metaplasia and the Progression to Esophageal Adenocarcinoma -- Differences in the Molecular Biology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third -- Clinical Staging of Adenocarcinoma of the Esophagogastric Junction -- Endoscopic Mucosal Resection for Staging and Therapy of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third -- Surgical Strategies for Adenocarcinoma of the Esophagogastric Junction -- Current Status of Sentinel Lymph Node Biopsy in Adenocarcinoma of the Distal Esophagus, Gastric Cardia, and Proximal Stomach -- Current Diagnosis and Future Impact of Micrometastases for Therapeutic Strategies in Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third -- Quality Indicators of Surgery for Adenocarcinoma of the Esophagus and Gastroesophageal Junction -- Peri-Operative and Complication Management for Adenocarcinoma of the Oesophagus and Oesophagigastric Junction -- Multimodality Therapy for Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third -- Metabolic Response Evaluation by PET During Neoadjuvant Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction -- Molecular Response Prediction in Multimodality Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction. |
520 ## - SUMMARY, ETC. |
Summary, etc |
Among malignant tumors, adenocarcinomas of the esophagogastric junction show the highest increase in incidence over the past three decades in Western industrialized countries. Accordingly, much effort is being devoted to basic and translational research in order to combat this frequently deadly disease. This special volume, with contributions from experts in the field, covers all aspects of adenocarcinomas of the esophagogastric junction. Etiology, pathogenesis, classification, and clinical staging are discussed, and there is special emphasis on state of the art treatment techniques. The latter range from endoscopic mucosal resections or limited surgical resections for early cancers to multimodality treatment options for locally advanced tumors. Emerging quality issues in surgical management are also addressed. Detailed attention is paid to other important recent developments, including molecular response prediction in multimodality treatment and early metabolic response evaluation by PET and PET-CT during neoadjuvant treatment. The diagnosis of micrometastases and its potential impact on therapeutic strategies are explored, and the use of sentinel node technology is assessed. This volume will be of interest to all clinicians concerned with the diagnosis and management of this malignancy. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine. |
|
Topical term or geographic name as entry element |
Internal medicine. |
|
Topical term or geographic name as entry element |
Pneumology. |
|
Topical term or geographic name as entry element |
Oncology. |
|
Topical term or geographic name as entry element |
Medicine & Public Health. |
|
Topical term or geographic name as entry element |
Oncology. |
|
Topical term or geographic name as entry element |
Internal Medicine. |
|
Topical term or geographic name as entry element |
Pneumology/Respiratory System. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Display text |
Printed edition: |
International Standard Book Number |
9783540705789 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-3-540-70579-6 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Item type |
E-Book |